Bowel (colorectal) cancer, Gastro oesophageal cancer, Kidney cancer, Prostate cancer, Renal cell cancer, Stomach cancer
Open
Phase 1/2
This trial is looking at the best dose of HTL0039732 for certain that have spread to another part of the body. It is also looking at the best dose of HTL0039732 to have with atezolizumab.
The trial is for people whose cancer is getting worse and there is no standard treatment available.
A solid tumour is any cancer apart from cancers of the blood such as and .
Cancer Research UK supports this trial.
Recruitment start: 23 June 2023
Recruitment end: 30 September 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Bristi Basu
Cancer Research UK (Centre for Drug Development)
Sosei Heptares
Last reviewed: 5 May 2025
CRUK internal database number: 18821
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
